BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 11936520)

  • 1. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
    Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
    Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.
    Takahashi H; Fujishima T; Koba H; Murakami S; Kurokawa K; Shibuya Y; Shiratori M; Kuroki Y; Abe S
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1109-14. PubMed ID: 10988138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.
    Honda Y; Kuroki Y; Shijubo N; Fujishima T; Takahashi H; Hosoda K; Akino T; Abe S
    Respiration; 1995; 62(2):64-9. PubMed ID: 7784711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.
    Honda Y; Kuroki Y; Matsuura E; Nagae H; Takahashi H; Akino T; Abe S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1860-6. PubMed ID: 8520747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
    McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ
    Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases.
    Kuwano K; Maeyama T; Inoshima I; Ninomiya K; Hagimoto N; Yoshimi M; Fujita M; Nakamura N; Shirakawa K; Hara N
    Respirology; 2002 Mar; 7(1):15-21. PubMed ID: 11896896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein D (SP-D) and systemic scleroderma (SSc).
    Maeda M; Ichiki Y; Aoyama Y; Kitajima Y
    J Dermatol; 2001 Sep; 28(9):467-74. PubMed ID: 11603386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis.
    Kuroki Y; Tsutahara S; Shijubo N; Takahashi H; Shiratori M; Hattori A; Honda Y; Abe S; Akino T
    Am Rev Respir Dis; 1993 Mar; 147(3):723-9. PubMed ID: 8442609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
    Takahashi H; Kuroki Y; Tanaka H; Saito T; Kurokawa K; Chiba H; Sagawa A; Nagae H; Abe S
    Am J Respir Crit Care Med; 2000 Jul; 162(1):258-63. PubMed ID: 10903251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
    Kinder BW; Brown KK; McCormack FX; Ix JH; Kervitsky A; Schwarz MI; King TE
    Chest; 2009 Jun; 135(6):1557-1563. PubMed ID: 19255294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
    Papaioannou AI; Kostikas K; Manali ED; Papadaki G; Roussou A; Spathis A; Mazioti A; Tomos I; Papanikolaou I; Loukides S; Chainis K; Karakitsos P; Griese M; Papiris S
    PLoS One; 2016; 11(6):e0157789. PubMed ID: 27337142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
    Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
    Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
    Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the determination of surfactant proteins A and D in assessing the activity of lung sarcoidosis.
    Beketov VD; Lebedeva MV; Mukhin NA; Serova AG; Ponomarev AB; Popova EN; Yanakaeva AS; Solomka VA; Kondrashov AV; Konovalov DV
    Ter Arkh; 2018 Apr; 90(3):42-46. PubMed ID: 30701855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Phelps DS; Umstead TM; Mejia M; Carrillo G; Pardo A; Selman M
    Chest; 2004 Feb; 125(2):617-25. PubMed ID: 14769746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone.
    Ikeda K; Shiratori M; Chiba H; Nishikiori H; Yokoo K; Saito A; Hasegawa Y; Kuronuma K; Otsuka M; Yamada G; Takahashi H
    Respir Med; 2017 Oct; 131():184-191. PubMed ID: 28947028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].
    Abe S; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.